People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MBF Therapeutics, Inc. | — | Biotechnology | Seed | $3.0M | $674K | 2023 |
Aris Persidis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aris Persidis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher M. Cashman | 1 | 6 |
| Joseph Connor | 1 | 2 |
| Christopher Cashman | 1 | 2 |
| Christopher M. Ragland | 1 | 1 |
| Dhiren Thakker | 1 | 1 |
| Christopher Ragland | 1 | 1 |
| Lorraine Keller | 1 | 1 |
| Chris M. Bunge | 1 | 1 |
| Aris M. Persidis | 1 | 1 |
| Dhiren M. Thakker | 1 | 1 |
| Thomas Tillett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.